The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Mar. 18, 2015
Applicant:

Academia Sinica, Taipei, TW;

Inventors:

Andrew H. -J. Wang, Taipei, TW;

Kai-Fa Huang, Taipei, TW;

Yan-Ping Shih, Taipei, TW;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/70 (2006.01); C07K 14/52 (2006.01); C12P 21/02 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
C12N 15/70 (2013.01); C07K 14/52 (2013.01); C12N 9/104 (2013.01); C12P 21/02 (2013.01); C12Y 203/02005 (2013.01); C07K 2319/21 (2013.01); C07K 2319/24 (2013.01); C07K 2319/50 (2013.01);
Abstract

Disclosed herein is an expression system and uses thereof. The expression system comprises two vectors that express two fusion proteins and a glutaminyl cyclase (QC) with E45Q mutation, so as to autonomously produce a target protein having a N-terminal pyroglutamate (pGlu) residue in a host cell. The first fusion protein is composed of a maltose binding protein (MBP) and a tobacco etch virus protease (TEVP); and the second fusion protein includes in sequence, a thioredoxin, a S-tag, a linker having a TEVP recognition site therein, a target protein, and a (His)--tag. The second fusion protein is cleaved by the TEVP that is expressed by the first fusion protein, and then catalyzed by QC with E45Q mutation so as to autonomously produce the target protein having a N-terminal pGlu residue in the host cell.


Find Patent Forward Citations

Loading…